Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

✍ Scribed by Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner

• Book ID: 117289334
• Publisher: The Lancet
• Year: 2005
• Tongue: English
• Weight: 164 KB
• Volume: 365
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(05)66374-x